Optofluidic And Proteomic Barcoding Platforms For Multi-Omic, Single-Cell And Bulk Analysis

The phenome, the complete set of phenotypic traits expressed by a cell or organism, is a key focus in modern biology. By characterizing the phenome at the single-cell level, we can gain invaluable insights into cellular function and unlock new avenues for discovery and therapeutic development.

Bruker offers a suite of technologies designed to enable the next wave of biological breakthroughs. Our platforms, including the IsoSpark Proteomic Barcoding System and the Beacon Optofluidic System, provide comprehensive phenome profiling capabilities, allowing researchers to:

Reveal a new dimension of behavior: Discover rare subsets of highly functionally active cells and understand the functional biological drivers of persistence, potency, and durability.

Access the bulk proteome with ease: Perform high-plex walk-away immunoassays to gain insights from low sample volumes.

Process and analyze cells in a faster, more insightful way: Use optofluidics to selectively sort and assay individual cells in NanoPen chambers, accelerating the path to live cell function and recovery.

With Bruker's innovative technologies, researchers can accelerate their path to biological solutions and drive the development of next-generation therapeutics.